Global X Lithium & Battery Tech ETF vs Tempus AI — how do they compare? Global X Lithium & Battery Tech ETF trades at $69.73 (market cap $1.45B), while Tempus AI trades at $70.93 (market cap $12.58B). The key difference: Tempus AI is far larger — about 8.7× Global X Lithium & Battery Tech ETF's market cap, and Global X Lithium & Battery Tech ETF is more actively traded (89,392 versus 7,444,569). Which is the better fit depends on your goals — on Pluang, investors hold Global X Lithium & Battery Tech ETF for 56 Days and Tempus AI for 23 Days on average.
| LIT | TEM | |
|---|---|---|
Market Cap | $1.45B | $12.58B |
Volume | 89,392 | 7,444,569 |
Sector | Commodities - Metals/Agriculture | Broad Market / Factor |
52-Week High | $91.62 | $99.28 |
52-Week Low | $53.92 | $41.55 |
Typical Hold Time | 56 Days | 23 Days |
Enterprise Value | — | $13.21B |
Signals from Pluang's Aura AI — not financial advice
LIT trades at $69.73, up 0.32% with mixed technical signals showing a bullish overall trend but bearish moving averages and oscillators. The ETF's price action remains volatile, trading near key support/resistance levels. Recent news highlights significant short interest reduction and ongoing exposure to the lithium and battery technology sector, which faces both supply chain challenges and long-term growth potential from electric vehicle adoption.
The outlook for LIT is cautiously optimistic, driven by global EV adoption trends and energy storage demand, though tempered by lithium price volatility and competitive pressures. Key risks include commodity price swings and geopolitical factors affecting battery supply chains, while institutional sentiment shows mixed signals with technical indicators suggesting near-term consolidation.
Tempus AI (TEM) trades at $69.28, down 1.44% today, with a bullish technical signal despite bearish moving averages. The company shows strong revenue growth (2026: $1.4B) but remains unprofitable with negative margins. Recent FDA clearance for ECG-MR AI product and ESMO Congress presentations highlight innovation momentum. Analyst consensus is strongly bullish with 64% buy ratings and $72.60 price target.
TEM offers growth potential in AI-driven healthcare diagnostics but carries significant execution risk due to persistent losses. The stock's high P/S ratio (8.61) reflects growth expectations, yet negative ROE (-67.44%) and insider selling warrant caution. Upside depends on profitability improvements and commercial adoption of new AI products.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →